In a strategic push to strengthen its U.S. generics business, Lupin has introduced a generic version of brimonidine tartrate and timolol maleate ophthalmic solution, a widely prescribed combination for reducing intraocular pressure in patients with glaucoma or ocular hypertension. The launch in the world’s largest pharmaceutical market underscores Lupin’s commitment to enhancing its specialty generics portfolio while addressing critical therapeutic areas. Industry estimates place the annual U.S. market for this category at approximately Rs.